![David Cook](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Cook
Hoofd Techniek/Wetenschap/O&O bij
FORMA THERAPEUTICS HOLDINGS, INC.
Profiel
Dr. David N.
Cook is a Chief Scientific Officer & Senior Vice President at Forma Therapeutics Holdings, Inc. and a Chief Executive Officer & Director at Edgewood Oncology, Inc. He is on the Board of Directors at Novome Biotechnologies, Inc., Global HIV Vaccine Enterprise, Edgewood Oncology, Inc. and X-Biotix Therapeutics, Inc. Dr. Cook was previously employed as a Chief Scientific Officer & Executive VP-Research by Seres Therapeutics, Inc., a Chief Operating Officer by International AIDS Vaccine Initiative, Inc., a Head-Business Advocacy by Bio Ventures for Global Health, a Chief Executive Officer by Anza Therapeutics, Inc., a Senior Vice President-Research & Development by Cerus Corp., and a Senior Vice President-Research & Development by COULTER CELLULAR THERAPIES INC.
He received his undergraduate degree from Harvard College and a doctorate degree from the University of California, Berkeley.
Actieve functies van David Cook
| Bedrijven | Functie | Begin |
|---|---|---|
| FORMA THERAPEUTICS HOLDINGS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 |
Global HIV Vaccine Enterprise
 Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Develops preventive HIV vaccines | Directeur/Bestuurslid | 01-06-2011 |
X-Biotix Therapeutics, Inc.
 X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Bestuurslid | - |
Eerdere bekende functies van David Cook
| Bedrijven | Functie | Einde |
|---|---|---|
| SERES THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2019 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Operationeel Directeur | 01-10-2012 |
Bio Ventures for Global Health
 Bio Ventures for Global Health Bio Ventures for Global Health is an organization focused on leveraging biotechnology to address global health challenges. The non-profit company is based in Washington, DC. It collaborates with various stakeholders to develop innovative solutions for diseases that disproportionately affect low-resource settings. Through strategic partnerships and initiatives, the company aims to improve health outcomes and access to healthcare in underserved communities worldwide. The CEO of the company is James C. Greenwood. | Corporate Officer/Principal | 01-02-2010 |
| CERUS CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-11-2007 |
Eligix, Inc.
 Eligix, Inc. Medical/Nursing ServicesHealth Services Develops and distributes medicines | Hoofd Techniek/Wetenschap/O&O | 01-08-2001 |
Opleiding van David Cook
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
66
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Eligix, Inc.
Eligix, Inc. Medical/Nursing ServicesHealth Services Develops and distributes medicines | Health Services |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes novel therapeutics to transform the patient living | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bio Ventures for Global Health
Bio Ventures for Global Health Bio Ventures for Global Health is an organization focused on leveraging biotechnology to address global health challenges. The non-profit company is based in Washington, DC. It collaborates with various stakeholders to develop innovative solutions for diseases that disproportionately affect low-resource settings. Through strategic partnerships and initiatives, the company aims to improve health outcomes and access to healthcare in underserved communities worldwide. The CEO of the company is James C. Greenwood. | |
Anza Therapeutics, Inc.
 Anza Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic vaccines for cancer and infectious diseases | Health Technology |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Develops preventive HIV vaccines | Commercial Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell-based therapeutics through the engineering of commensal gut microbes | Commercial Services |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
